F-18 FLUORODEOXYGLUCOSE PET IMAGING ALTERS CLINICAL DECISION-MAKING IN PATIENTS WITH IMPAIRED VENTRICULAR-FUNCTION

Citation
Rsb. Beanlands et al., F-18 FLUORODEOXYGLUCOSE PET IMAGING ALTERS CLINICAL DECISION-MAKING IN PATIENTS WITH IMPAIRED VENTRICULAR-FUNCTION, The American journal of cardiology, 79(8), 1997, pp. 1092
Citations number
15
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
79
Issue
8
Year of publication
1997
Database
ISI
SICI code
0002-9149(1997)79:8<1092:FFPIAC>2.0.ZU;2-U
Abstract
The effect of F-18-fluorodeoxyglucose positron emission tomography ima ging on decision making in the selection of patients with impaired ven tricular function for revascularization was determined in 87 patients. In 57% of patients, positron emission tomography data influenced mana gement decisions, indicating an important effect of myocardial Viabili ty determination on difficult therapy decisions in these patients.